Ask Warren

ABL Bio

298380 · KOSDAQ · ₩298380 · 에이비엘바이오

₩39,200▼ ₩1,800 (4.39%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩20B₩13B₩0₩1.4B₩76B₩2.2B₩9.1B₩7.9B
Operating income−₩17B−₩17B−₩30B−₩22B₩41B−₩29B−₩19B−₩15B
Net income−₩341M−₩15B−₩28B−₩21B₩40B−₩28B−₩19B−₩13B
Net income to shareholders−₩15B−₩14B−₩28B−₩21B₩40B−₩28B−₩19B−₩13B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩274B₩298B₩281B₩235B₩244B₩211B₩232B₩245B
Current assets₩170B₩194B₩176B₩130B₩140B₩113B₩144B₩157B
Cash and equivalents₩165B₩187B₩112B₩124B₩133B₩23B₩56B₩150B
Total liabilities₩100B₩115B₩124B₩53B₩60B₩68B₩65B₩64B
Current liabilities₩99B₩114B₩123B₩52B₩59B₩66B₩63B₩20B
Borrowings₩17B₩55B₩55B—————
Total equity₩174B₩183B₩157B₩182B₩184B₩143B₩167B₩181B
Shareholders' equity₩171B₩181B₩155B₩182B₩184B₩143B₩167B₩181B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩23B₩33B−₩24B−₩28B₩38B−₩28B−₩16B−₩18B
Free cash flow−₩23B₩33B−₩24B−₩28B₩38B−₩28B−₩16B−₩18B

Consolidated where available. Amounts in won.

Also known as: ABL Bio / 에이비엘바이오 / 298380 / KRX:298380

Source: KRX statistical information